Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
1.
Dig Dis Sci ; 2024 Jun 05.
Artigo em Inglês | MEDLINE | ID: mdl-38837110

RESUMO

BACKGROUND: The increasing global incidence and prevalence of inflammatory bowel disease (IBD) necessitates an investigation into the potential influence of environmental risk factors on its origin. AIM: This multicenter case-control study aimed to investigate potential environmental risk factors contributing to IBD development in Turkey. METHODS: The study included 156 Crohn's disease (CD), 277 ulcerative colitis (UC) patients, and 468 controls (matched for age and gender) from six hospitals' gastroenterology departments. Data collection relied on the International Organization of IBD's questionnaire on environmental factors. Each environmental factor was initially analyzed using univariate and subsequently multivariate logistic regression models. RESULTS: In the multivariate model, regular coffee consumption was associated with decreased odds for both CD (OR 0.28; 95% CI 0.14-0.55) and UC (OR 0.25; 95% CI 0.15-0.42). Stress was associated with UC (OR 3.27; 95% CI 1.76-6.10) and CD (OR 4.40; 95% CI 2.12-9.10) development. A history of childhood infectious diseases (gastroenteritis, upper respiratory tract infections, etc.) raised the odds for both CD (OR 9.45; 95% CI 2.51-35.6) and UC (OR 7.56; 95% CI 1.57-36.4). Conversely, consuming well/spring water (OR 0.22; 95% CI 0.10-0.50) and childhood antibiotic use (OR 0.41; 95% CI 0.18-0.93) showed a positive association against UC. Increased consumption of refined sugar and industrial food products emerged as risk factors for IBD. Smoking increased the risk for CD (OR 2.38; 95% CI 1.16-4.91), while ex-smoking increased the risk for UC (OR 3.16; 95% CI 1.19-8.37). CONCLUSIONS: This study represents the first multicenter case-control study in Turkey examining the effects of environmental factors on IBD. It revealed that coffee consumption is positively associated, while stress and childhood infection-related diseases are risk factors. These findings, which are not supported by other studies, provide insight into the relationships between these factors and IBD.

2.
Ulus Travma Acil Cerrahi Derg ; 29(12): 1382-1384, 2023 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-38073451

RESUMO

Percutaneous Endoscopic Gastrostomy (PEG) is a simple and effective method of enteral nutrition in many patients who cannot take oral food. The accidental dislodgement of the PEG tube after the maturation of the gastro-cutaneous fistula (stoma) is called late dislodgement. If it is not detected early, the stoma lumen gets narrower; and does not permit the passage of the replacement tube. In this case, the commonly followed method is to continue enteral nutrition by opening a new gastro-cutaneous fistula after the complete closing of the original stoma. Here, we present a stoma-saving bougie dilatation method in 3 cases with severely narrowed stomas after late accidental dislodgement of the PEG tube.


Assuntos
Fístula Cutânea , Estomas Cirúrgicos , Humanos , Gastrostomia/efeitos adversos , Gastrostomia/métodos , Dilatação/efeitos adversos , Nutrição Enteral/efeitos adversos , Nutrição Enteral/métodos
4.
Ann Transplant ; 20: 596-603, 2015 Oct 06.
Artigo em Inglês | MEDLINE | ID: mdl-26438974

RESUMO

BACKGROUND: Hepatocellular carcinoma (HCC) is the fifth most common tumor worldwide, with an incidence equal to the death rate. MATERIAL AND METHODS: We aimed to detect the prognostic factors for HCC patients. We retrospectively analyzed 12 years data of 115 patients who have biopsy-proven HCC. Clinical and demographic characteristics of patients with treatment modalities, survival rates, and prognostic factors were analyzed. RESULTS: There were 93 male patients, and the mean age was 63.5±11.8 years. Most patients had cirrhosis due to hepatitis virus infection. Median follow-up time was 17 months (1 month-9.5 years) after the diagnosis of HCC. The nodule was single in 43 (37.4%) patients, there were 2-3 nodules in 30 (26.1%), and >3 or diffuse nodules in 42 (36.5%) patients. Distribution of treatment modalities was as follows: 23 (20%) patients had liver transplantation, 15 (13%) had HCC resection, 12 patients (10.4%) had radiofrequency ablation (RFA), 26 patients (22.6%) had transarterial chemoembolization (TACE), 2 (1.7%) had alcohol ablation, and 37 patients (32.2%) had no treatment. Tumor sizes of 9 patients (39.1%) in the transplanted group exceeded the Milan criteria. Mean survival was 72±6.9, 78.8 ±12.5, 19.5±2.8, 20.6±4.2, 16.0±5.9 months in those that received transplantation, resection, RFA, TACE, and no treatment, respectively (p<0.001). Survival was significantly poorer in patients >63 years old (p=0.001), with serum albumin level ≤3.4 g/dL (p=0.01), and with diffuse HCC (p<0.001). CONCLUSIONS: Survival was significantly better in patients who underwent liver transplantation or surgical resection. Tumor number, age, and serum albumin level were the most important prognostic factors related to overall survival.


Assuntos
Carcinoma Hepatocelular/mortalidade , Carcinoma Hepatocelular/terapia , Causas de Morte , Neoplasias Hepáticas/mortalidade , Neoplasias Hepáticas/terapia , Idoso , Biópsia por Agulha , Carcinoma Hepatocelular/patologia , Ablação por Cateter/métodos , Ablação por Cateter/mortalidade , Quimioembolização Terapêutica/métodos , Quimioembolização Terapêutica/mortalidade , Estudos de Coortes , Bases de Dados Factuais , Intervalo Livre de Doença , Feminino , Hepatectomia/métodos , Hepatectomia/mortalidade , Humanos , Imuno-Histoquímica , Estimativa de Kaplan-Meier , Neoplasias Hepáticas/patologia , Transplante de Fígado/métodos , Transplante de Fígado/mortalidade , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Medição de Risco , Taxa de Sobrevida , Turquia
5.
World J Gastroenterol ; 20(41): 15241-52, 2014 Nov 07.
Artigo em Inglês | MEDLINE | ID: mdl-25386072

RESUMO

Gastrointestinal endoscopy has a major diagnostic and therapeutic role in most gastrointestinal disorders; however, limited information is available about clinical efficacy and safety in pregnant patients. The major risks of endoscopy during pregnancy include potential harm to the fetus because of hypoxia, premature labor, trauma and teratogenesis. In some cases, endoscopic procedures may be postponed until after delivery. When emergency or urgent indications are present, endoscopic procedures may be considered with some precautions. United States Food and Drug Administration category B drugs may be used in low doses. Endoscopic procedures during pregnancy may include upper gastrointestinal endoscopy, percutaneous endoscopic gastrostomy, sigmoidoscopy, colonoscopy, enteroscopy of the small bowel or video capsule endoscopy, endoscopic retrograde cholangiopancreatography and endoscopic ultrasonography. All gastrointestinal endoscopic procedures in pregnant patients should be performed in hospitals by expert endoscopists and an obstetrician should be informed about all endoscopic procedures. The endoscopy and flexible sigmoidoscopy may be safe for the fetus and pregnant patient, and may be performed during pregnancy when strong indications are present. Colonoscopy for pregnant patients may be considered for strong indications during the second trimester. Although therapeutic endoscopic retrograde cholangiopancreatography may be considered during pregnancy, this procedure should be performed only for strong indications and attempts should be made to minimize radiation exposure.


Assuntos
Colangiopancreatografia Retrógrada Endoscópica , Doenças do Sistema Digestório/diagnóstico , Doenças do Sistema Digestório/terapia , Endoscopia Gastrointestinal , Endossonografia , Complicações na Gravidez/diagnóstico , Complicações na Gravidez/terapia , Ultrassonografia Pré-Natal/métodos , Analgésicos/efeitos adversos , Colangiopancreatografia Retrógrada Endoscópica/efeitos adversos , Endoscopia Gastrointestinal/efeitos adversos , Endossonografia/efeitos adversos , Feminino , Feto/efeitos dos fármacos , Humanos , Hipnóticos e Sedativos/efeitos adversos , Seleção de Pacientes , Valor Preditivo dos Testes , Gravidez , Lesões Pré-Natais/etiologia , Medição de Risco , Fatores de Risco , Resultado do Tratamento , Ultrassonografia Pré-Natal/efeitos adversos
6.
Ann Transplant ; 16(3): 88-96, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21959515

RESUMO

BACKGROUND: Pulmonary disorders are among the commonly encountered and prognostically important problems in patients with chronic liver disease. To define the prevalence and types of respiratory disorders in patients with advanced liver disease evaluated for liver transplant (LT) candidacy, and to determine factors affecting postoperative outcome. MATERIAL/METHODS: The records of 341 adult patients evaluated for LT candidacy were retrospectively examined. Demographic, clinical and laboratory data including chest X-ray, spirometry and echocardiography results were collected. Postoperative pulmonary complications and mortality rates were determined. RESULTS: With a mean age of 45.1 years, 73 (21.4%) patients presented with respiratory symptoms or signs. The most common radiographic abnormality on chest X-ray was right diaphragm elevation (53.2%). Hypoxemia was detected in 38.1% of the patients. Pulmonary hypertension was detected in 100 of 327 (30.6%) patients on Doppler echocardiography. There were 141 patients who underwent surgery. Postoperative pulmonary complications developed in 60 patients, with pneumonia being the most prevalent complication (n=28). Smoking, emphysema, abnormal spirometry, pulmonary hypertension, hypoxia and orthodeoxia were found to be factors associated with increased postoperative pulmonary complications (P<0.05 for all). Mortality rate was 24.1% (n=34) and found to be significantly higher in patients who developed a postoperative complication than in those who did not (38.7% vs. 13.8%, respectively; p=0.001). CONCLUSIONS: The authors' findings indicate that pulmonary disorders impact prognosis and are common in patients evaluated for LT candidacy. Postoperative pulmonary complication is one of the major factors affecting mortality. Therefore, in order to increase the success of the transplant operation, a thorough preoperative pulmonary evaluation is of paramount importance.


Assuntos
Transplante de Fígado , Pneumopatias/diagnóstico , Adolescente , Adulto , Idoso , Gasometria , Ecocardiografia Doppler , Feminino , Humanos , Hipertensão Pulmonar/complicações , Hipóxia/complicações , Transplante de Fígado/efeitos adversos , Transplante de Fígado/mortalidade , Pneumopatias/complicações , Pneumopatias/diagnóstico por imagem , Masculino , Pessoa de Meia-Idade , Complicações Pós-Operatórias/diagnóstico , Complicações Pós-Operatórias/etiologia , Período Pré-Operatório , Prognóstico , Capacidade de Difusão Pulmonar , Radiografia , Testes de Função Respiratória , Estudos Retrospectivos , Fatores de Risco , Fumar/efeitos adversos , Adulto Jovem
8.
Dig Dis Sci ; 54(6): 1237-42, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18975085

RESUMO

BACKGROUND: Balloon dilatation of the lower esophageal sphincter (LES) is one of the effective nonsurgical treatment options in the management of achalasia. We aimed to determine the long-term results of graded balloon dilatation and the factors predicting outcome. PATIENTS: Patients followed for more than 12 months between January 1995 to March 2005, without history of endoscopic or surgical therapy before the study, were included (n = 111, mean age 46.3 +/- 16.9 years; follow-up period 46.3 [12-150] months). Patients were evaluated by barium swallow contrast studies, upper endoscopy, and esophageal manometry. Pneumatic dilatation was performed with the use of polyethylene balloon system. Patient outcome was evaluated according to manometric studies and Van Trappen staging as determined following face-to-face interviews with the patients. RESULTS: We determined clinical response rates of 98%, 85.7%, and 75% at months 24, 48, and 60. According to receiver-operating characteristics (ROC) analysis, age or=30.5 mmHg, LESP after first balloon dilatation >or=17.5 mmHg, and balloon number >2 were found to negatively affect treatment response. Young age and higher esophageal body pressure at admission were determined to be negative predictive factors (P = 0.038, relative risk (RR) 2.6, 95% confidence interval [CI] 1.05-6.4 and P = 0.05, RR 1.069, 95% CI 0.99-1.14, respectively). CONCLUSION: Balloon dilatation is an effective treatment of achalasia. Young age, higher esophageal body pressure, and high LESP after first balloon dilatation are negative predictive factors. Patients with young age requiring more than two balloon dilatations are likely to be unresponsive to the treatment.


Assuntos
Cateterismo , Acalasia Esofágica/terapia , Esofagoscopia , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Resultado do Tratamento
9.
Liver Transpl ; 14(4): 541-6, 2008 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18383083

RESUMO

Living donor liver transplantation has acquired widespread acceptance. A thorough workup of the potential living donor is guided by 2 objectives: the first is ensuring the safety of the surgical procedure for the donor, and the second is identifying donor grafts that pose potential risks for the recipient. Of 305 living-related liver donors, liver biopsy was performed in 201. The results of those patients' liver function tests and serologic tests were within normal limits. Forty-one of the 201 patients had steatosis on abdominal ultrasonography or tomography. Of 201 liver biopsies, 94 (46.8%) demonstrated normal findings, whereas 107 (53.2%) showed abnormal findings on pathology. Of 107 patients with abnormal pathological findings, 32 (29.9%) had fatty changes, 4 (3.7%) had steatohepatitis, and 71 (66.4%) had nonsteatotic histologic findings including fibrosis, hepatitis, and granulomatous reactions. In conclusion, our data show that half of the living-related liver donors, appearing absolutely healthy, had biopsies with abnormal pathology results. As it is well known that increasing percentages of steatosis may reduce the functional mass of the graft and occult liver diseases may not be detected without liver biopsy, we recommend that liver biopsies be part of the routine evaluation protocol for living-related liver donors in all transplantation institutions.


Assuntos
Biópsia , Fígado , Doadores Vivos , Seleção de Pacientes , Humanos , Fígado/citologia , Fígado/patologia , Hepatopatias/epidemiologia , Anamnese , Exame Físico , Cuidados Pré-Operatórios , Estudos Retrospectivos
10.
Dig Dis Sci ; 53(9): 2380-6, 2008 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-18205046

RESUMO

INTRODUCTION: Gastroesophageal reflux disease (GERD) is a very common disorder that substantially affects the patient's quality of life. AIM: Our aim was to detect the frequency of GERD in patients with hiatal hernia (HH), to compare the acid reflux pattern in patients with and without HH, and to search the relationship between the erosive gastroesophageal reflux (GER) and HH. METHODS: Forty patients with HH diagnosed by at least two methods, and 121 patients with GERD as a control group were studied. The frequency of GERD in patients with HH, the acid reflux pattern, the relation of body mass index and erosive esophagitis with HH and control group was studied. RESULTS: Among patients with HH 67.5% of patients had GER. On comparison of acid reflux pattern, the isolated distal esophageal reflux was seen more in patients with HH than in the control group (P < 0.0001). Erosive GERD was seen more in patients with HH than in the control group (P = 0.017). There was no difference in body mass indices between patients with HH and erosive gastroesophageal reflux disease and patients with HH and non-erosive GERD. CONCLUSION: Hiatal hernia is very closely associated with GERD, and isolated distal esophageal reflux is seen more in patients with HH than in patients without HH. There is no effect of body mass index on GER in patients with HH.


Assuntos
Refluxo Gastroesofágico/fisiopatologia , Hérnia Hiatal/fisiopatologia , Adulto , Índice de Massa Corporal , Estudos de Casos e Controles , Esofagite Péptica/complicações , Esofagite Péptica/fisiopatologia , Esôfago/patologia , Esôfago/fisiopatologia , Feminino , Refluxo Gastroesofágico/complicações , Hérnia Hiatal/complicações , Humanos , Concentração de Íons de Hidrogênio , Masculino , Pessoa de Meia-Idade , Prevalência
11.
Dig Dis Sci ; 52(12): 3440-3, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17410448

RESUMO

The outcome of renal transplantation is adversely affected by hepatitis B virus infection. We retrospectively analyzed data of 1,251 renal transplant recipients, 20 of whom were hepatitis B surface antigen positive and hepatitis B virus DNA negative at the time of renal transplantation. Hepatitis B virus reactivation was seen in 14 of the 20 patients at a mean time of 16.3+/-7.1 months after transplantation. All patients with hepatitis B virus reactivation after transplantation were treated with lamivudine, biochemical, and serologic response was achieved in 13 of 14 patients at a mean time of 7.0+/-1.1 months. Seven of 13 patients experienced a breakthrough at a mean time of 9.2+/-6.2 months. Three of the 20 patients died at a mean time of 57.0+/-38.5 months after transplantation. Our data demonstrated that chronic immunosuppression is associated with a significantly high risk of hepatitis B virus reactivation in renal transplant recipients and hepatitis B reactivation does not increase the likelihood of graft rejection or patient mortality after renal transplantation.


Assuntos
Vírus da Hepatite B/fisiologia , Hepatite B Crônica/virologia , Transplante de Rim , Lamivudina/uso terapêutico , Inibidores da Transcriptase Reversa/uso terapêutico , Adolescente , Adulto , Biópsia , DNA Viral/genética , Ensaio de Imunoadsorção Enzimática , Feminino , Seguimentos , Antígenos de Superfície da Hepatite B/imunologia , Antígenos E da Hepatite B/imunologia , Vírus da Hepatite B/genética , Vírus da Hepatite B/imunologia , Hepatite B Crônica/tratamento farmacológico , Hepatite B Crônica/patologia , Humanos , Fígado/patologia , Masculino , Pessoa de Meia-Idade , Reação em Cadeia da Polimerase , Estudos Retrospectivos , Resultado do Tratamento , Ativação Viral
12.
Dig Dis Sci ; 52(11): 3217-23, 2007 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-17406825

RESUMO

In this study, we investigated possible independent predictive factors for survival, other than MELD score, in patients with cirrhosis. We reviewed the serum sodium, cholesterol, albumin, and platelet levels of 99 patients with cirrhosis and investigated the possible correlation of these parameters with survival period. We found that 77% and 81% of patients with cirrhosis were hypocholesterolemic and hypoalbuminemic, respectively. We noted that the survival time of 6 months in patients with serum sodium levels <125 mM at the time of admission to the study was 27% less than that in patients with sodium levels >130 mM. Patients with cirrhosis and serum sodium levels >130 mM survived for more than 1 year (95% CI). MELD scores of patients with serum sodium levels >130, between 125 and 129, and <125 mM were 15.8 to 19.9, 19.7 to 23.6, and 23.3 to 27.2, respectively (95% CI). In conclusion, we suggest that although all of these parameters are correlated with survival in patients with cirrhosis, the serum sodium level is the most accurate prognostic factor and a valid tool for predicting survival when considered in combination with the MELD score.


Assuntos
Falência Hepática/mortalidade , Transplante de Fígado/estatística & dados numéricos , Listas de Espera , Adulto , Fatores Etários , Idoso , Biomarcadores/sangue , Feminino , Seguimentos , Humanos , Falência Hepática/sangue , Falência Hepática/cirurgia , Masculino , Pessoa de Meia-Idade , Prognóstico , Estudos Retrospectivos , Fatores de Risco , Fatores Sexuais , Sódio/sangue , Taxa de Sobrevida/tendências , Fatores de Tempo , Turquia/epidemiologia
13.
Dig Dis Sci ; 52(5): 1299-303, 2007 May.
Artigo em Inglês | MEDLINE | ID: mdl-17356915

RESUMO

Endoscopic findings have been described for the diagnosis of celiac disease but the relationship among the clinical presentation, endoscopic markers, and the degree of histopathological findings is not clear. Thirty patients who were thought to have celiac disease were included in this study. Biopsies taken from the duodenum were examined histopathologically. The relationship among the endoscopic, clinical, and histopathological findings were investigated. Partial villous atrophy was seen in 14 patients (46.6%), and subtotal and total villous atrophy were seen in 6 (20%) patients each. Eighty six percent of patients with a mosaic appearance, 76% of patients with the finding of loss of folds, and 90% of patients with scalloping on endoscopy had either partial villous atrophy, subtotal villous atrophy, or total villous atrophy on biopsy. We conclude that endoscopic findings in celiac disease can reveal valuable information both for diagnosis and for demonstration of the severity of the disease state.


Assuntos
Doença Celíaca/diagnóstico , Duodenoscopia , Duodeno/patologia , Mucosa Intestinal/patologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Atrofia , Doença Celíaca/patologia , Doença Celíaca/fisiopatologia , Duodeno/fisiopatologia , Feminino , Humanos , Masculino , Microvilosidades/patologia , Pessoa de Meia-Idade , Valor Preditivo dos Testes , Sensibilidade e Especificidade , Índice de Gravidade de Doença , Turquia
14.
Dig Dis Sci ; 52(11): 3081-6, 2007 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-17393310

RESUMO

Systemic sclerosis (SSc) is a connective tissue disorder of unknown etiology characterized by fibrosis and vascular obliteration in the skin, gastrointestinal tract, lungs, and heart. Our aim was to investigate the autoantibody profile in patients with esophageal involvement of SSc and to describe the relationship between the autoantibody profile and organ involvement in SSc. We studied 47 SSc patients, all with esophageal involvement shown on esophageal manometry. The patients were separated into three groups based on the absence or presence of ANA, Scl70, and ACA. In this study ANA and Scl70 were present more frequently than ACA in patients with esophageal involvement of SSc. Pulmonary involvement and heart involvement were seen more in Scl70-positive and ACA-positive patients, respectively. We conclude that in patients with SSc, closer follow-up with autoantibody profile may enable early diagnosis of specific organ involvement and treatment of debilitating symptoms, with avoidance of potential life-threatening complications.


Assuntos
Autoanticorpos/imunologia , Doenças do Esôfago/etiologia , Cardiopatias/etiologia , Pneumopatias/etiologia , Escleroderma Sistêmico/imunologia , Adulto , Anticorpos Antinucleares/imunologia , Biomarcadores , Centrômero/imunologia , DNA Topoisomerases Tipo I/imunologia , Ecocardiografia Doppler , Eletrocardiografia , Ensaio de Imunoadsorção Enzimática , Doenças do Esôfago/epidemiologia , Doenças do Esôfago/fisiopatologia , Esôfago/fisiopatologia , Feminino , Seguimentos , Cardiopatias/diagnóstico , Cardiopatias/epidemiologia , Humanos , Incidência , Pneumopatias/diagnóstico , Pneumopatias/epidemiologia , Masculino , Manometria , Pessoa de Meia-Idade , Proteínas Nucleares/imunologia , Pressão , RNA/imunologia , Testes de Função Respiratória , Escleroderma Sistêmico/complicações , Escleroderma Sistêmico/epidemiologia , Turquia/epidemiologia
16.
Dig Dis Sci ; 52(3): 798-802, 2007 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-17245629

RESUMO

We sought to investigate the frequency and distribution of colorectal cancer (CRC) in patients by age and to evaluate whether there is a difference between young (<40 years of age) and older patients ( > or = 40 years of age) with regard to cancer localizations. From a total of 5165 colonoscopies, 314 (6.0%) cases were identified to have colorectal carcinoma. Forty-one (13%) of 314 CRC patients were young, with a mean age of 31.1 +/- 5.7 years. When cancer localizations were compared with reference to age, it was seen that CRCs in young patients were mostly localized at the right colon, versus at the left colon and rectum (P = 013) in patients >40 years of age. Tumor localizations in colon cancer patients change with age. In our study, young patients tended to have right-sided colon tumors, but those in patients >40 years of age were frequently localized at the left colon and rectum.


Assuntos
Colonoscopia , Neoplasias Colorretais/diagnóstico , Neoplasias Colorretais/epidemiologia , Programas de Rastreamento/estatística & dados numéricos , Adolescente , Adulto , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos
17.
Pediatr Transplant ; 10(5): 639-43, 2006 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16857005

RESUMO

Wilson's disease is a hereditary disorder of copper metabolism that results in the accumulation of copper in the body, primarily in the liver, brain, and cornea. Hepatocellular carcinoma, in contrast to other causes of cirrhosis, is seldom associated with Wilson's disease. We present a 12-yr-old boy with Wilson's disease in whom hepatocellular carcinoma was incidentally diagnosed in the pathologic specimen examined after liver transplantation.


Assuntos
Carcinoma Hepatocelular/etiologia , Degeneração Hepatolenticular/complicações , Degeneração Hepatolenticular/cirurgia , Neoplasias Hepáticas/etiologia , Transplante de Fígado , Criança , Humanos , Achados Incidentais , Masculino
18.
Turk J Gastroenterol ; 17(3): 252-5, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17438649

RESUMO

Various disorders of the hepatobiliary system can occur due to sickling in patients with sickle cell anemia. Pathology and frequency of these disorders are not clearly known. Liver biopsies of these patients show erythrocytosis, erythrophagocytosis, sinusoidal dilatation and hyperplasia in Kupffer cells. We present a 21-year-old male patient diagnosed with sickle cell anemia who developed chronic liver disease, together with a review of the literature.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA